Amryt Pharma

24 results

Venn Life Sciences chief executive Tony Richardson. Venn has established full-service clinical research programmes and activities in 27 different countries

Clinical trials group Venn Life Sciences has signed a strategic collaboration with Open Orphan DAC as it seeks to increase its focus on rare diseases (...)

Dublin’s Iseq index slid to its lowest level since immediately after the Brexit referendum on Monday. Photograph: AFP/Getty Images

Dublin’s Iseq index slid to its lowest level since immediately after the Brexit referendum, as fears mounted over the prospect of the United Kingdom c(...)

Taoiseach Leo Varadkar and Minister for Innovation Heather Humphreys unveiled the 27 projects to share funding. Photograph: Ulien Behal Photography

A scheme to help communities generate their own electricity, new treatments for sepsis, and advanced 3D printing of medical implants are just some of (...)

Dr Elaine Sullivan, Carrick Therapeutics, winner of the Emerging award at the EY Entrepreneur of the Year Awards, which took place in Citywest. Photograph: Dave Meehan for the Irish Times

Dr Elaine Sullivan, co-founder and chief executive of early-stage life-sciences company Carrick Therapeutics, has won top prize in the emerging catego(...)

In Dublin, insurer FBD Holdings rose by 2.5 per cent to €10.25.

Ireland’s Iseq index advanced for the first time in five sessions, led by insurer FBD Holdings and nutrition giant Kerry Group, as the wider European (...)

Dublin-based Amryt said it’s making “strong progress” with its lead development asset, a drug for the treatment of Epidemolysis Bullosa (EB). Photograph: iStock

Sales of Amryt Pharma’s lead commercial drug increased 14.6 per cent in the first half of 2018 as the group significantly expanded the locations in wh(...)

Amryt said the US Food and Drug Administration had given it  approval which will enable the opening of US clinical trials on their drug AP101.

Irish pharmaceutical company Amryt said on Monday that it had received IND (investigational new drug) approval from the US authorities that will allow(...)

Amryt Pharma chief executive Joe Wiley.

Irish pharmaceutical company Amryt Pharma has won a designation for one of its key drugs which could make it eligible for a voucher ultimately worth u(...)

Amryt Pharma chief executive Joe Wiley said the move was another step on the road as the company looked to make the drug available in more territories.

Irish biopharmaceutical group Amryt Pharma’s flagship product Lojuxta has been approved for funding as an NHS England treatment for adults. Lojuxta i(...)

Amryt Pharma founder Dr Joe Wiley: “A good entrepreneur knows how to delegate.”

In 2015, Dr Joe Wiley founded Amryt Pharma to focus on acquiring, developing and delivering innovative treatments that help improve the lives of patie(...)

  • 1
  • 2
  • 3
  • Next
  • Last »